Orgenesis Inc

+0.08 (+1.68%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)118.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9 Million
Adjusted EPS-$0.03
See more estimates
10-Day MA$4.84
50-Day MA$5.02
200-Day MA$5.47
See more pivots

Orgenesis Inc Stock, NASDAQ:ORGS

20271 Goldenrod Lane, 20271 Goldenrod Lane, Germantown, Maryland 20876
United States of America
Phone: +1.480.659.6404
Number of Employees: 111


Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Point-Of-Care Cell Therapy (POC) segments. The CDMO segment through MaSTherCell, comprises of services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The POC segment provides multitude of cell therapies including, but not limited to, cell-based immunotherapies, therapeutics for metabolic diseases, neurodegenerative diseases and tissue regeneration. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.